Cremagin Spherical Adsorbent
spherical carbonaceouse adsorbent 2g
Prescription medication
HK inno.N Co., Ltd.
MFDS item code 200401539 · Approved 2004.03.31 · Insurance code 640002511
Delay in initiation of dialysis in advanced chronic kidney disease; improvement of uremic symptoms
This medication aids in improving the symptoms of uremia and delaying the initiation of dialysis when symptoms of uremia occur as chronic kidney disease progresses. It contributes to enhancing the quality of life for patients.
Adults: Take 2 grams (1 sachet) per dose, 3 times daily
This medication should not be used in patients with gastrointestinal obstruction as it may cause issues due to improper excretion of the drug. It should be used cautiously in patients with gastrointestinal ulcers or esophageal varices since the drug may irritate the affected areas as it passes through the gastrointestinal tract in solid form. Caution is also required for patients prone to constipation, as this medication may exacerbate constipation, and there is a potential increase in blood ammonia levels in patients with liver dysfunction. Gastrointestinal symptoms such as constipation, loss of appetite, nausea, vomiting, and abdominal bloating may occur during the use of this medication. If symptoms are severe, measures such as discontinuing or reducing the medication dosage may be necessary. There have also been reports of side effects such as constipation, abdominal bloating, indigestion, headache, and skin rash with long-term use. In patients with progressive chronic kidney disease, serum creatinine levels should be checked before administration, and caution should be exercised if renal function is moderately or severely impaired. During medication use, serum creatinine levels and changes in symptoms of uremia should be monitored periodically. If no effect is observed after about 6 months of administration, discontinuation or consideration of alternative therapies should be evaluated. Due to its adsorbent properties, it is advisable not to take this medication with other drugs, as it may reduce the effects of those medications. The safety of this drug during pregnancy or breastfeeding has not been sufficiently established, so it should only be used when the therapeutic benefits outweigh the risks. Safety has not been established in children, especially premature infants, neonates, and young children, so caution is advised in use. Elderly patients may experience more side effects due to decreased bodily functions, so special care is necessary when using this medication.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light and at a temperature between 1°C and 30°C. Storing it this way helps maintain the drug's efficacy for a longer time.
Black spherical particles
84 sachets (3 sachets x 28, 2g/sachet)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
spherical carbonaceouse adsorbent 2g
Prescription medication
HK inno.N Co., Ltd.

spherical carbonaceouse adsorbent 285.7mg
Hard capsule · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

spherical carbonaceouse adsorbent 2mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.